Navigation Links
Rosetta Genomics Announces Exclusive Distribution Agreement With Teva Pharmaceutical Industries Ltd.
Date:1/8/2009

ivate Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including risks related to: Rosetta's approach to discover microRNA technology and to work on the application of this technology in the development of novel diagnostics and therapeutic tools, which is unproven and may never lead to commercially accepted products or services; Rosetta's ability to obtain, maintain and protect its intellectual property; Rosetta's ability to enforce its patents against infringers and to defend its patent portfolio against challenges from third parties; Rosetta's need and ability to obtain additional funding to support its business activities; Rosetta's dependence on third parties for development, manufacture, marketing, sales, and distribution of products; Rosetta's ability to successfully develop its candidate tools, products and services,; Rosetta's ability to obtain regulatory clearances or approvals that may be required for its products and services; the ability to obtain coverage and adequate payment from health insurers for the products and services comprising Rosetta's technology; competition from others using technology similar to Rosetta's and others developing products for similar uses; Rosetta's dependence on collaborators; and Rosetta's short operating history; as well as those risks more fully discussed in the "Risk Factors" section of Rosetta's Annual Report on Form 20-F for the year ended December 31, 2007 as filed with the Securities and Exchange Commission. In addition, any forward-looking statements represent Rosetta's views only as of the date of this release and should not be relied upon as representing its views as of any subsequent date. Rosetta does not assume any obligation to update any forward-looking statements unless required by law.

    Contact:
    Media& Investors
    Ron Kamienchi
'/>"/>
SOURCE Rosetta Genomics Ltd
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Rosetta Genomics Announces Annual General Meeting of Shareholders to be Held on September 24, 2007
2. NYU Medical Center Collaborates With Rosetta Genomics to Develop a microRNA-Based Diagnostic Test for Melanoma
3. Rosetta Genomics to Present at the American Association of Cancer Research (AACR) "Molecular Diagnostics in Cancer Therapeutic Development" Conference
4. Rosetta Genomics to Webcast Presentation at Maxim Group Growth Conference
5. Rosetta Genomics to Host and Webcast its R&D Day on Friday, October 26, 2007
6. Rosetta Genomics Will Host and Webcast its R&D Day on Friday, October 26, 2007
7. Rosetta Genomics Announces Initiation of In Vivo Studies Following Successful Completion of First Milestone in MicroRNA-based Therapeutic Program for Liver Cancer
8. Rosetta Genomics Selects PCR as Platform for its microRNA-based Diagnostics to be Launched in 2008, Licensed Nanogens MGB Probe Technology
9. Rosetta Genomics and Columbia University Medical Center to Develop MicroRNA-based Diagnostics for Leukemia and Non Hodgkin Lymphoma
10. Rosetta Genomics Announces Initiation of Expansion of US Operations to Facilitate Expected Product Launches in 2008
11. Henry Ford Hospital and Rosetta Genomics to Develop MicroRNA-based Diagnostics for Brain Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/29/2014)... CHESTERBROOK, Pa. , Sept. 29, 2014 /PRNewswire/ ... of the largest global pharmaceutical sourcing and distribution ... analysis on coffee consumption. This research was analyzed ... coffee consumption was associated with an increase in ... The study looked at population-level coffee consumption across ...
(Date:9/27/2014)... the peer-reviewed Journal of Animal Science concludes ... has no impact on the health or productivity of ... and field data sets, the article documents evidence that ... crops are comparable with those of animals fed non-GE ... feed crops have become an increasing component of livestock ...
(Date:9/27/2014)... Researchers from The University of Texas at Dallas have ... wearable computers with self-contained power sources or, more immediately, ... of heavy use. , This technology, published online in ... power of a single electron to control energy consumption ... modern electronic systems. , Researchers from the Erik Jonsson ...
(Date:9/26/2014)... , Sept. 26, 2014  MicroBiome Therapeutics ... results from a proof of concept study testing ... the tolerability of metformin, the first-line therapy for ... of metformin and active ingredients contained in the ... an effective, safe and inexpensive medication, is recommended ...
Breaking Biology Technology:Coffee Consumption May Increase Survival and Reduce Healthcare Costs 2Coffee Consumption May Increase Survival and Reduce Healthcare Costs 3New UT Dallas technology may lead to prolonged power in mobile devices 2New UT Dallas technology may lead to prolonged power in mobile devices 3Positive Proof Of Concept Study Shows MicroBiome Therapeutics' NM505 May Improve Tolerability Of Metformin In Type 2 Diabetes 2Positive Proof Of Concept Study Shows MicroBiome Therapeutics' NM505 May Improve Tolerability Of Metformin In Type 2 Diabetes 3
... Calif., May 6 Finesse Solutions, LLC,Santa ... control solutions for,life sciences process applications, announced ... of Software. Basil brings over 19 years ... a focus on,implementing high efficiency engineering, resource ...
... Award at Leading Venture Contest Makes Carnegie Mellon ,Winningest, ... ... time, a team of,students from the Tepper School of Business at Carnegie ... competition Moot,Corp(R). This year,s winning venture business -- NeuroBank -- has developed,a ...
... Md., May 6 PharmAthene, Inc.,(Amex: PIP ) ... threats, announced today that its financial results,for the first ... 13, 2008., PharmAthene management will be hosting a ... The call is scheduled to begin at,4:30 p.m. Eastern ...
Cached Biology Technology:Basil Zimmo Joins Finesse Solutions as Vice-President of Software 2Tepper School Team Takes Top Honors at Global Moot Corp(R) Competition 2PharmAthene to Host First Quarter 2008 Conference Call and Webcast on Tuesday, May 13, 2008 2
(Date:9/29/2014)... Monday, September 29: Between 1970 and 2010 populations ... the globe dropped 52 percent, says the 2014 ... Fund (WWF). This biodiversity loss occurs disproportionately in ... of high-income countries. , In addition to the ... point to other warning signs about the overall ...
(Date:9/29/2014)... Texas at Arlington research team says recently identified radiation ... lab could open doors for homeland security and medical ... the Oct. 1 issue of Optics Letters , ... describe a new method to fabricate transparent nanoscintillators by ... a transparent ceramic is formed. A scintillator refers ...
(Date:9/29/2014)... received a five-year, $6 million grant for clinical ... and development of safe and effective treatments for ... the National Institutes of Health, National Institute on ... Medication Development for Cocaine Use Disorder to oversee ... decisions on moving forward with more expensive large-scale ...
Breaking Biology News(10 mins):Half of global wildlife lost, says new WWF report 2UT Arlington researchers develop new transparent nanoscintillators for radiation detection 2UT Arlington researchers develop new transparent nanoscintillators for radiation detection 3New VCU center to target cocaine addiction 2
... of a tiny shrimp-like species, known scientifically as ... non-native quagga mussels in the Great Lakes, say NOAA ... Diporeia and many aquatic species have steadily ... NOAA,s Great Lakes Environmental Laboratory published,this week in ...
... University have developed a new tool that makes it possible ... generation of blood vessels. The researchers, findings, published in ... enable scientists to determine what signals in the body attract ... tumor research. The new invention is a tiny cell ...
... a startling result, a new study published by the ... than 80 percent of the world,s major armed conflicts ... biologically diverse and threatened places on Earth. Titled ... conservation scientists compared major conflict zones with the Earth,s ...
Cached Biology News:Tiny tool to control growing blood vessels opens new potential in tumor research 2Study finds most wars occur in Earth's richest biological regions 2Study finds most wars occur in Earth's richest biological regions 3
Preparation TW--Compatibility: Push-on end cap seals suitable up to 70 C only -Hybridization Tube for Model HB-1D -Comp Dim: 200 80 mm -Material: borosilicate glass -Mfr Desig: Techne FHB-12...
Preparation TW--Compatibility: no end cap seals -Hybridization Tube for Hybrigene -Comp Dim: 240 80 mm -Material: borosilicate glass -Mfr Desig: Techne FHB-15...
...
... in hybridization incubators with rotators. Graduated, ... size PP plug-seal screw-cap with O-ring ... three lengths to accept different size ... O-rings available separately. • Comp Dim: ...
Biology Products: